Máj- és epeúti rák: vizsgálatok itt: Vietnám
6 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.
- No phaseTaking peopleENPP1/cGAS (EG) and FAP Expression Profiles in Solid Tumors: An Immunohistochemical Study in a Vietnamese Cohort
- Where
- Hanoi, Ho Chi Minh City
- Életkor
- 18 év and over
- People
- 162
- Run by
- Tam Anh Research Institute
See details and how to joinNCT07808164 - 3. fázisTaking peoplePhase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
- Where
- Da Nang, Hanoi, Ho Chi Minh City, Vinh
- Életkor
- 18 év to 99 év
- People
- 620 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06467357 · EU 2023-508057-19-00 - 3. fázisTaking peoplePhase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
- Where
- Hanoi, Ho Chi Minh City
- Életkor
- 18 év and over
- People
- 1220 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06921785 · EU 2024-518210-81-00 - No phaseTaking peopleAnalysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic Cancer.
- Where
- Ho Chi Minh City
- Életkor
- 18 év to 80 év
- People
- 50
- Run by
- Gene Solutions
See details and how to joinNCT06227728 - 3. fázisTaking peopleStudy of ADI-PEG 20 Versus Placebo in Subjects With High Arginine Level and Unresectable Hepatocellular Carcinoma
- Where
- Hanoi, Hà Nội, Huế
- Életkor
- 18 év to 99 év
- People
- 300 worldwide
- Run by
- Polaris Group
See details and how to joinNCT05317819 - No phaseCsak meghívásosClinical Validation of an MCED Test in Symptomatic Populations (K-ACCELERATE)
- Where
- Ho Chi Minh City
- Életkor
- 18 év and over
- People
- 1000
- Run by
- Gene Solutions
See details and how to joinNCT06391749